longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Infusystem

INFU

12.0101.01% ( +0.120 )
Trading: Sep 9, 10:54:56 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 27.72, within the reasonable range, cheaper than 73.56% of the time in the past 1 years, and the industry ranks 17/74, the industry Median --.

27.72xP/E
$11.89Stock price
$0.43Earnings per share
27.72xP/E
Stock price$11.89Earnings per share$0.43

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
29.52x
Typical range
24.85x–34.83x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
07142128

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
CVSUSCVS Health
25.13x394.45%$122.87B
LHUSLabcorp
26.29x33.20%$26.35B
DGXUSQuest Diagnostics
24.57x16.13%$25.99B
BTSGUSBrightSpring Health Services
33.82x86.70%$12.38B
CHEUSChemed
27.58x26.04%$7.59B
CRVLUSCorVel
29.64x--$3.42B
ADUSUSAddus Homecare
21.16x18.07%$2.23B
VMDUSViemed Healthcare
23.09x11.71%$334.80M
INFUUSInfusystem
27.72x37.64%$236.82M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.